Relmada Therapeutics
RLMD
RLMD
86 hedge funds and large institutions have $44.9M invested in Relmada Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
73% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 40
85% less call options, than puts
Call options by funds: $140K | Put options by funds: $914K
Holders
86
Holding in Top 10
–
Calls
$140K
Puts
$914K
Top Buyers
| 1 | +$378K | |
| 2 | +$328K | |
| 3 | +$302K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$300K |
| 5 |
GIM
Guild Investment Management
Los Angeles,
California
|
+$281K |
Top Sellers
| 1 | -$700K | |
| 2 | -$467K | |
| 3 | -$448K | |
| 4 |
Two Sigma Investments
New York
|
-$323K |
| 5 |
Millennium Management
New York
|
-$299K |